WO2006041843A3 - Pharmaceutical dosage form comprising meloxicam - Google Patents

Pharmaceutical dosage form comprising meloxicam Download PDF

Info

Publication number
WO2006041843A3
WO2006041843A3 PCT/US2005/035686 US2005035686W WO2006041843A3 WO 2006041843 A3 WO2006041843 A3 WO 2006041843A3 US 2005035686 W US2005035686 W US 2005035686W WO 2006041843 A3 WO2006041843 A3 WO 2006041843A3
Authority
WO
WIPO (PCT)
Prior art keywords
meloxicam
dosage form
pharmaceutical dosage
powder
fever
Prior art date
Application number
PCT/US2005/035686
Other languages
French (fr)
Other versions
WO2006041843A2 (en
Inventor
Pratibha Kuldeep Bhat
Amit Mukharya
Praveen Reddy Billa
Mailatur Sivaraman Mohan
Original Assignee
Reddys Lab Ltd Dr
Reddys Lab Inc Dr
Pratibha Kuldeep Bhat
Amit Mukharya
Praveen Reddy Billa
Mailatur Sivaraman Mohan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr, Reddys Lab Inc Dr, Pratibha Kuldeep Bhat, Amit Mukharya, Praveen Reddy Billa, Mailatur Sivaraman Mohan filed Critical Reddys Lab Ltd Dr
Publication of WO2006041843A2 publication Critical patent/WO2006041843A2/en
Publication of WO2006041843A3 publication Critical patent/WO2006041843A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Meloxicam powder having a mean particle size of about 2 µm to about 25 µm, pharmaceutical compositions containing the powder, a process to prepare the compositions, and their use in the treatment of conditions such as inflammation, pain, fever and arthritis.
PCT/US2005/035686 2004-10-04 2005-10-04 Pharmaceutical dosage form comprising meloxicam WO2006041843A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1023/CHE/2004 2004-10-04
IN1023CH2004 2004-10-04

Publications (2)

Publication Number Publication Date
WO2006041843A2 WO2006041843A2 (en) 2006-04-20
WO2006041843A3 true WO2006041843A3 (en) 2006-08-24

Family

ID=36148840

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/035686 WO2006041843A2 (en) 2004-10-04 2005-10-04 Pharmaceutical dosage form comprising meloxicam

Country Status (1)

Country Link
WO (1) WO2006041843A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107970219A (en) * 2017-12-27 2018-05-01 佛山市南海东方澳龙制药有限公司 Pet meloxicam tablet and its preparation method and application

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009534387A (en) * 2006-04-19 2009-09-24 ノヴァデル ファーマ インコーポレイテッド Stable hydroalcoholic oral spray formulations and methods
JP5508003B2 (en) 2006-06-30 2014-05-28 アイスイティカ ピーティーワイ リミテッド Process for the preparation of biologically active compounds in nanoparticulate form
MX351930B (en) 2009-04-24 2017-11-03 Iceutica Pty Ltd A novel formulation of indomethacin.
MA33294B1 (en) * 2009-04-24 2012-05-02 Iceutica Pty Ltd A process for producing nanoparticle powder for commercial use
BRPI1014279B1 (en) * 2009-04-24 2020-03-17 Iceutica Pty Ltd A NEW FORMULATION OF MELOXICAM
WO2011026080A1 (en) * 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
RU2465892C1 (en) * 2011-09-21 2012-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет (НГУ)" Method of obtaining highly dispersed meloxicame
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229038A1 (en) * 2003-03-03 2004-11-18 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229038A1 (en) * 2003-03-03 2004-11-18 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107970219A (en) * 2017-12-27 2018-05-01 佛山市南海东方澳龙制药有限公司 Pet meloxicam tablet and its preparation method and application

Also Published As

Publication number Publication date
WO2006041843A2 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
WO2006041843A3 (en) Pharmaceutical dosage form comprising meloxicam
IL213597A0 (en) Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL195294A (en) Process for producing high purity safinamide or ralfinamide, use thereof in the preparation of medicaments and pharmaceutical formulations containing them
IL178822A (en) 4-phenylamino-quinazolin-6-yl-amides, pharmaceutical compositions comprising the same and use thereof in the preparation of medicaments for the treatment of proliferative disorders
IL171683A (en) Immunosuppressant compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy
IL164373A (en) Benzamide derivatives, pharmaceutical compositions containing them, process for their preparation and use thereof in the manufacture of medicaments and as medicaments in the treatment of diseases associated with cancer
IL196891A (en) (3-amino-1,2,3,4-tetrahydro-9h-carbazol--9-yl)-acetic acid derivatives, pharmaceutical compositions containing them and their use in the preparation of medicaments
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
IL203923A (en) Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds
IL193762A (en) Compounds useful in inhibiting dgat1-related disorders, pharmaceutical compositions comprising them and use thereof in preparation of medicaments
IL231576A (en) Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments
IL169954A (en) Tricyclo substituted amide compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for the treatment of a condition where activation of gk is desirable
IL164845A (en) 2-(alpha-hydroxypentyl)benzoate, its preparation, pharmaceutical compositions comprising it and their use in the preparation of medicaments
IL198612A (en) Human antibodies to human delta like ligand 4, method for producing the same, compositions comprising them and use thereof in the preparation of medicaments
PL396568A1 (en) Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate
WO2006085101A3 (en) Pharmaceutical compositions useful in the transmucosal administration of drugs
IL181524A (en) Heterocyclic compounds, pharmaceutical compositions containing them and their use in the manufacture of medicaments
IL165532A (en) Aryl carbonyl derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for treating metabolic disorders
IL196775A (en) 2,4-bis(3-methyl-morpholin-4-yl)-7-phenyl-pyrido[2,3-d]pyrimidine derivatives, pharmaceutical compositions comprising them and use thereof as medicaments and in the manufacture of medicaments
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
IL183108A (en) Triazole compounds, pharmaceutical compositions containing them and their use in the manufacture of medicaments for treating proliferation disorders
IL188494A0 (en) Novel 2,4-dianlinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
IL174647A (en) Pyrazolopyridines and analogs thereof, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL183974A (en) 5h-benzocycloheptane tetralin and indane derivatives, pharmaceutical compositions comprising them and uses thereof in the preparation of medicaments

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05807615

Country of ref document: EP

Kind code of ref document: A2